» Articles » PMID: 35571159

Adenosine A2a Receptor Regulates Autophagy Flux and Apoptosis to Alleviate Ischemia-Reperfusion Injury the CAMP/PKA Signaling Pathway

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Exploring effective methods to lessen myocardial ischemia-reperfusion injury still has positive significance. The adenosine A2a receptor (A2aR) has played a crucial part in cardiac ischemia-reperfusion injury. Previous studies revealed that the adenosine A2a receptor regulated autophagy, but the specific mechanism in myocardial ischemia-reperfusion injury was still unclear. We established an ischemia-reperfusion model (30 min of ischemia and 2 h of reperfusion) and a model with oxygen-glucose deprivation for 6 h and reoxygenation for 18 h (OGDR) . The ischemia-reperfusion injury resulted in prolonged QTc interval, left ventricular systolic dysfunction, and myocardial infarction. model, we found that the OGDR-induced autophagosomes and apoptosis caused myocardial cell death, as evidenced by a significant increase in the generation of lactate dehydrogenase and creatine kinase-MB. Furthermore, overactivated autophagy with rapamycin showed an anti-apoptotic effect. The interaction between autophagy and apoptosis in myocardial ischemia-reperfusion injury was complex and variable. We discovered that the activation of adenosine A2a receptor could promote the expression of Bcl-2 to inhibit the levels of Beclin-1 and LC3II. The number of autophagosomes exceeded that of autolysosomes under OGDR, but the result reversed after A2aR activation. Activated A2aR with its agonist CGS21680 before reperfusion saved cellular survival through anti-apoptosis and anti-autophagy effect, thus improving ventricular contraction disorders, and visibly reducing myocardial infarction size. The myocardial protection of adenosine A2a receptor after ischemia may involve the cAMP-PKA signaling pathway and the interaction of Bcl-2-Beclin-1.

Citing Articles

Gallic acid pretreatment mitigates parathyroid ischemia-reperfusion injury through signaling pathway modulation.

Liu N, Liang H, Hong Y, Lu X, Jin X, Li Y Sci Rep. 2024; 14(1):12971.

PMID: 38839854 PMC: 11153493. DOI: 10.1038/s41598-024-63470-5.


Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine AR improves hepatic and cardiac dysfunction of NASH mice.

Huang C, Yeh H, Lin R, Liao T, Shen H, Yang Y Am J Physiol Gastrointest Liver Physiol. 2024; 326(4):G385-G397.

PMID: 38252682 PMC: 11213477. DOI: 10.1152/ajpgi.00104.2023.


The effect of extracorporeal shock wave on joint capsule fibrosis based on AAR-Nrf2/HO-1 pathway in a rat extending knee immobilization model.

Yuan H, Wang K, Zhang Q, Wang F, Zhou Y J Orthop Surg Res. 2023; 18(1):930.

PMID: 38057890 PMC: 10699066. DOI: 10.1186/s13018-023-04420-1.


Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of Conditioning Techniques: Clinical Evidence.

Kumar K, Singh N, Yadav H, Maslov L, Jaggi A Curr Cardiol Rev. 2023; 19(6):56-71.

PMID: 37309766 PMC: 10636797. DOI: 10.2174/1573403X19666230612112259.


Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders.

Mlambo R, Liu J, Wang Q, Tan S, Chen C Pharmaceuticals (Basel). 2023; 16(4).

PMID: 37111360 PMC: 10142280. DOI: 10.3390/ph16040603.


References
1.
Ye B, Chen X, Dai S, Han J, Liang X, Lin S . Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes. Drug Des Devel Ther. 2019; 13:975-990. PMC: 6438141. DOI: 10.2147/DDDT.S195412. View

2.
Maiuri M, Le Toumelin G, Criollo A, Rain J, Gautier F, Juin P . Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 2007; 26(10):2527-39. PMC: 1868901. DOI: 10.1038/sj.emboj.7601689. View

3.
Aghaei M, Motallebnezhad M, Ghorghanlu S, Jabbari A, Enayati A, Rajaei M . Targeting autophagy in cardiac ischemia/reperfusion injury: A novel therapeutic strategy. J Cell Physiol. 2019; 234(10):16768-16778. DOI: 10.1002/jcp.28345. View

4.
Chen L, Sampson K, Kass R . Cardiac Delayed Rectifier Potassium Channels in Health and Disease. Card Electrophysiol Clin. 2016; 8(2):307-22. PMC: 4893812. DOI: 10.1016/j.ccep.2016.01.004. View

5.
Grisanti L, Thomas T, Carter R, de Lucia C, Gao E, Koch W . Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling. Theranostics. 2018; 8(17):4664-4678. PMC: 6160776. DOI: 10.7150/thno.26619. View